Anatara Lifesciences Ltd (AU:ANR) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Anatara Lifesciences Limited has announced a change in the director’s interests, with John Michailidis acquiring 359,640 performance rights following shareholder approval at their recent AGM. This update indicates potential strategic moves within the company that may interest investors watching director activities closely.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.